HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nesrin Dogan Selected Research
Nesrin Dogan Research Topics
Disease
18
Neoplasms (Cancer)
01/2024 - 01/2002
14
Prostatic Neoplasms (Prostate Cancer)
01/2024 - 01/2002
4
Head and Neck Neoplasms (Head and Neck Cancer)
01/2024 - 04/2002
4
AIDS-Related Complex (ARC)
11/2018 - 04/2016
4
Breast Neoplasms (Breast Cancer)
11/2018 - 01/2006
3
Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 09/2018
1
Neoplasm Metastasis (Metastasis)
12/2022
1
Adenocarcinoma
08/2020
1
Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2018
1
Lung Neoplasms (Lung Cancer)
07/2013
1
Edema (Dropsy)
06/2002
Drug/Important Bio-Agent (IBA)
4
Gold
IBA
12/2022 - 01/2018
3
Protons (Proton)
IBA
01/2021 - 01/2021
1
Androgens
IBA
12/2022
1
Biomarkers (Surrogate Marker)
IBA
05/2021
1
1- ethyl- 3- (3- dimethylaminopropyl)carbodiimide N-hydroxysuccinimide
IBA
01/2021
1
N-hydroxysuccinimide
IBA
01/2021
1
Antibodies
IBA
01/2021
1
Antigens
IBA
01/2021
1
Carbodiimides
IBA
01/2021
1
Luciferases
IBA
11/2018
1
DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)
IBA
11/2018
1
deoxyuridine triphosphate
IBA
11/2018
1
Ligands
IBA
01/2018
1
ErbB Receptors (EGF Receptor)
IBA
09/2017
1
Fluorescent Dyes (Fluorescent Probes)
IBA
09/2017
1
Polylactic Acid-Polyglycolic Acid Copolymer
IBA
09/2017
1
Iodine
IBA
04/2016
1
Levonorgestrel (Plan B)
FDA Link
Generic
07/2013
Therapy/Procedure
23
Radiotherapy
01/2024 - 01/2002
6
Proton Therapy
01/2024 - 01/2021
6
Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
09/2022 - 01/2002
4
Therapeutics
01/2021 - 07/2013
3
Brachytherapy
05/2018 - 01/2002
1
Castration
12/2022
1
Intravenous Administration
01/2021
1
Neoadjuvant Therapy
08/2020